Many patients have heard of the condition PCOS, or polycystic ovary syndrome. It’s commonly heard of because it affects 1 in 8 women and it is the most common endocrine dysfunction disorder in reproductive age women. Now, experts are redesignating it as PMOS, which stands for polyendocrine metabolic ovarian syndrome. We are so excited about this name change because it much better reflects the syndrome that’s actually occurring.
The term polycystic ovary syndrome placed too much focus on the ovaries and on the idea of “cysts,” even though many patients with the condition do not have ovarian cysts at all. It also failed to capture how widely this condition can affect the body. In addition to irregular periods or ovulation issues, patients may experience acne, excess hair growth, hair thinning, insulin resistance, weight-related concerns, metabolic changes, inflammation, fatigue, anxiety, depression and emotional stress related to symptoms that can feel difficult to explain or manage.
That broader picture is why the new name matters. PMOS is intended to better reflect the fact that this is not just an ovarian / gynecologic issue. It is a condition that involves multiple hormone pathways and has effects across metabolic, reproductive, and overall health.
For patients, the most important takeaway is this: the redesignation does not mean your symptoms were misunderstood, and it does not mean your care needs to start over. What it should do is support a clearer and more complete understanding of the condition moving forward.
A more accurate name can lead to better conversations in the exam room. It may help patients feel more seen in the full scope of what they are experiencing, rather than feeling like the discussion begins and ends with fertility or ultrasound findings alone. It can also encourage a broader care approach that considers cycle health, ovulation, metabolic screening, long-term health risks, and each patient’s individual goals. Besides just OBGYNs and endocrinologists managing this condition, now also PCPs, weight loss and obesity medicine specialists can help to manage this. More specialists and taking a multidisciplinary approach often means you will have more comprehensive treatment and better outcomes.
In practice, that means patient care should continue to be individualized. Some patients may be focused on symptom relief. Others may be trying to conceive. Others may need support related to insulin resistance, skin changes, or cycle regulation. The redesignation to PMOS helps reinforce that good care should match the whole patient, not just one part of the diagnosis.
Names carry weight in medicine. When a condition’s name is too narrow, it can shape expectations in ways that leave patients feeling overlooked. A name that better reflects the full condition can help open the door to more accurate education, better recognition, and more comprehensive care. We hope that there will be expanded diagnostic criteria and new pharmacologic management in the future so that you will be able to get to a diagnosis sooner and have better treatment.
If you have questions about PCOS, PMOS, irregular cycles, ovulation, or fertility, our team is here to help you better understand what is going on and what next steps may make sense for you.
Feel free to check out our Instagram @annahealthfertility where we discuss this, as well!
